| US and International In-Hospital Costs of Extracorporeal Membrane Oxygenation: a Systematic Review MJ Harvey, MG Gaies, LA Prosser Applied health economics and health policy, 1 - 17, 2015 | 97 | 2015 |
| Rapid testing and treatment for sexually transmitted infections improve patient care and yield public health benefits GG Whitlock, DC Gibbons, N Longford, MJ Harvey, A McOwan, EJ Adams International journal of STD & AIDS 29 (5), 474-482, 2018 | 65 | 2018 |
| Aggregate health and economic burden of herpes zoster in the United States: illustrative example of a pain condition M Harvey, LA Prosser, AM Rose, IR Ortega-Sanchez, R Harpaz Pain 161 (2), 361-368, 2020 | 42 | 2020 |
| Modelling-based evaluation of the costs, benefits and cost-effectiveness of multipathogen point-of-care tests for sexually transmitted infections in symptomatic genitourinary … SE Huntington, RM Burns, E Harding-Esch, MJ Harvey, R Hill-Tout, ... BMJ open 8 (9), e020394, 2018 | 27 | 2018 |
| Use of the Aptima mRNA high-risk human papillomavirus (HR-HPV) assay compared to a DNA HR-HPV assay in the English cervical screening programme: a decision tree model based … G Weston, C Dombrowski, MJ Harvey, T Iftner, M Kyrgiou, C Founta, ... BMJ open 10 (3), e031303, 2020 | 21 | 2020 |
| Testing a method to develop preliminary cost estimates of homicide in Glasgow: A research note MJ Harvey, DJ Williams, PD Donnelly Criminal justice policy review 24 (4), 510-523, 2013 | 11 | 2013 |
| Antimicrobial resistance point-of-care testing for gonorrhoea treatment regimens: cost-effectiveness and impact on ceftriaxone use of five hypothetical strategies compared with … EM Harding-Esch, SE Huntington, MJ Harvey, G Weston, CE Broad, ... Eurosurveillance 25 (43), 1900402, 2020 | 10 | 2020 |
| Budget impact analysis of comprehensive genomic profiling in patients with advanced non–small-cell lung cancer MJ Harvey, R Cunningham, B Sawchyn, M Montesion, P Reddy, ... JCO Precision Oncology 5, 1611-1624, 2021 | 8 | 2021 |
| PMU30 cost-effectiveness analysis of newborn screening for spinal muscular atrophy (SMA) in the United States R Arjunji, J Zhou, A Patel, ML Edwards, M Harvey, M Soverino, ... Value in Health 23, S238, 2020 | 6 | 2020 |
| The “basic” approach: a single-centre experience with a cost-reducing model for paediatric cardiac extracorporeal membrane oxygenation MA Padalino, C Tessari, A Guariento, AC Frigo, VL Vida, A Marcolongo, ... Interactive CardioVascular and Thoracic Surgery 24 (4), 590-597, 2017 | 5 | 2017 |
| Hitting the Optimal Vaccination Percentage and the Risks of Error: Why to Miss Right MJ Harvey, LA Prosser, ML Messonnier, DW Hutton PLOS ONE 11 (6), e0156737, 2016 | 5 | 2016 |
| Determining the optimal strategy for the live-attenuated herpes zoster vaccine in adults MJ Harvey, BT Denton, LA Prosser, DW Hutton Vaccine 36 (41), 6237-6247, 2018 | 4 | 2018 |
| Assessing the transition from intravenous to subcutaneous delivery of rituximab: Benefits for payers, health care professionals, and patients with lymphoma MJ Harvey, Y Zhong, E Morris, JN Beverage, RS Epstein, AJ Chawla Plos one 17 (1), e0261336, 2022 | 3 | 2022 |
| P4. 36 Evaluating the costs, benefits and cost-effectiveness of multi-pathogen point-of-care tests for sexually transmitted infections in symptomatic genitourinary medicine … E Harding-Esch, SE Huntington, RM Burns, M Harvey, R Hill-Tout, ... Sexually Transmitted Infections 93 (Suppl 2), A205-A205, 2017 | 2 | 2017 |
| RO2 Assessing the relationship between lifelong value and pricing for orphan drugs in ultra-rare diseases O Dabbous, ZY Zhou, C Tang, M Harvey, EQ Wu, R Arjunji Value in Health 22, S388, 2019 | 1 | 2019 |
| Cost-Effectiveness Modeling of Prostate-Specific Membrane Antigen Positron Emission Tomography with Piflufolastat F 18 for the Initial Diagnosis of Patients with Prostate … CW Yee, MJ Harvey, Y Xin, NY Kirson PharmacoEconomics 42 (2), 231-247, 2024 | | 2024 |
| Exploring HCV eradication through diagnosis and treatment strategies MJ Harvey, CY Cheng, E Leone, A Postulka, EJ Adams EASL Mono-thematic Meeting, Berlin, 2018 | | 2018 |
| O15. 3 Cost-effectiveness of antimicrobial resistance point-of-care testing for optimising the treatment of gonorrhoea E Harding-Esch, SE Huntington, M Harvey, CE Broad, EJ Adams, ... Sexually Transmitted Infections 93 (Suppl 2), A34-A35, 2017 | | 2017 |
| Making Good Decisions: Examining the Cost-Effectiveness and Optimal Timing of the Herpes Zoster Vaccine MJ Harvey The University of Michigan, 2016 | | 2016 |
| Cost-Effectiveness of Single-Chamber Compared with Dual-Chamber and Single-Lead with Atrial Sensing Implantable Cardioverter Defibrillators DW Hutton, MJ Harvey, JP Thaker, JV Freeman Circulation 130 (suppl_2), A19452-A19452, 2014 | | 2014 |
Elisabeth AdamsCEO, Aquarius Population Healthכתובת אימייל מאומתת בדומיין aquariusph.com
